SEARCH

SEARCH BY CITATION

REFERENCES

  • Amano K, Nomura Y, Segawa M, Yamakawa K. 2000. Mutational analysis of the MECP2 gene in Japanese patients with Rett syndrome. J Hum Genet 45:231236.
  • Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. 1999. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23:185188.
  • Amir RE, Van den Veyver IB, Schultz R, Malicki DM, Tran CQ, Dahle EJ, Philippi A, Timar L, Percy AK, Motil KJ, Lichtarge O, Smith EO, Glaze DG, Zoghbi HY. 2000. Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes. Ann Neurol 47:670679.
  • Amir RE, Zoghbi HY. 2000. Rett syndrome: methyl-CpG-binding protein 2 mutations and phenotype–genotype correlations. Am J Med Genet 97:147152.
  • Antonarakis SE, Nomenclature Working Group. 1998. Recommendations for a nomenclature system for human gene mutations. Hum Mutat 11:13.
  • Cheadle JP, Gill H, Fleming N, Maynard J, Kerr A, Leonard H, Krawczak M, Cooper DN, Lynch S, Thomas N, Hughes H, Hulten M, Ravine D, Sampson JR, Clarke A. 2000. Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. Hum Mol Gen 9:11191129.
  • Chen RZ, Akbarian S, Tudor M, Jaenisch R. 2001. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 27:327331.
  • Claustres M, Horaitis O, Vanevski M, Cotton RGH. 2002. Time for a unified system of mutation description and reporting: a review of locus-specific mutation databases. Genome Res 12:680688.
  • Clayton-Smith J, Watson P, Ramsden S, Black GC. 2000. Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males. Lancet 356:830832.
  • den Dunnen JT, Antonarakis SE. 2000. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15:712.
  • Dotti MT, Orrico A, De Stefano N, Battisti C, Sicurelli F, Severi S, Lam CW, Galli L, Sorrentino V, Federico A. 2002. A Rett syndrome MECP2 mutation that causes mental retardation in men. Neurology 58:226230.
  • Ellaway C, Christodoulou J. 2001. Rett syndrome: clinical characteristics and recent genetic advances. Disabil Rehabil 23:98106.
  • Guy J, Hendrich B, Holmes M, Martin JE, Bird A. 2001. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 27:322326.
  • Hoang L, Byck S, Prevost L, Scriver CR. 1996. PAH muta-tion Analysis Consortium Database: a database for disease-producing and other allelic variation at the human PAH locus. Nucleic Acids Res 24:127131.
  • Huppke P, Laccone F, Kramer N, Engel W, Hanefeld F. 2000. Rett syndrome: analysis of MECP2 and clinical characterization of 31 patients. Hum Mol Gen 9:13691375.
  • Imessaoudene B, Bonnefont JP, Royer G, Cormier-Daire V, Lyonnet S, Lyon G, Munnich A, Amiel J. 2001. MECP2 mutation in non-fatal, non-progressive encephalopathy in a male. J Med Genet 38:171174.
  • Inui K, Akagi M, Ono J, Tsukamoto H, Shimono K, Mano T, Imai K, Yamada M, Muramatsu T, Sakai N, Okada S. 2001. Mutational analysis of MECP2 in Japanese patients with atypical Rett syndrome. Brain Dev 23:212215.
  • Kerr AM, Nomura Y, Armstrong D, Anvret M, Belichenko PV, Budden S, Cass H, Christodoulou J, Clarke A, Ellaway C, d'Esposito M, Francke U, Hulten M, Julu P, Leonard H, Naidu S, Schanen C, Webb T, Engerstrom IW, Yamashita Y, Segawa M. 2001. Guidelines for reporting clinical features in cases with MECP2 mutations, [see comments]. Brain Dev 23:208211.
  • Klauck SM, Lindsay S, Beyer KS, Splitt M, Burn J, Poustka A. 2002. A mutation hot spot for nonspecific X-linked mental retardation in the MECP2 gene causes the PPM-X syndrome. Am J Hum Genet 70:10341037.
  • Laccone F, Zoll B, Huppke P, Hanefeld F, Pepinski W, Trappe R. 2002. MECP2 gene nucleotide changes and their pathogenicity in males: proceed with caution. J Med Genet 39:586588.
  • Meloni I, Bruttini M, Longo I, Mari F, Rizzolio F, D'Adamo P, Denvriendt K, Fryns JP, Toniolo D, Renieri A. 2000. A mutation in the Rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males. Am J Hum Genet 67:982985.
  • Nowacki PM, Byck S, Prevost L, Scriver CR. 1997. The PAH Mutation Analysis Consortium Database: update 1996. Nucleic Acids Res 25:139142.
  • Nowacki PM, Byck S, Prevost L, Scriver CR. 1998. PAH mutation analysis consortium database: 1997. Prototype for relational locus-specific mutation databases. Nucleic Acids Res 26:220225.
  • Orrico A, Lam C, Galli L, Dotti MT, Hayek G, Tong SF, Poon PM, Zappella M, Federico A, Sorrentino V. 2000. MECP2 mutation in male patients with non-specific X-linked mental retardation. FEBS Lett 481:285288.
  • Trevathan E, Moser HW. 1988. Diagnostic criteria for Rett syndrome. Ann Neurol 23:425428.
  • Villard L, Kpebe A, Cardoso C, Chelly PJ, Tardieu PM, Fontes M. 2000. Two affected boys in a Rett syndrome family: clinical and molecular findings. Neurology 55:11881193.
  • Watson P, Black G, Ramsden S, Barrow M, Super M, Kerr B, Clayton-Smith J. 2001. Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. J Med Genet 38:224228.
  • Weaving LS, Williamson SL, Bennetts B, Davis M, Ellaway CJ, Leonard H, Thong MK, Delatycki M, Thompson EM, Laing N, Christodoulou J. Effects of MECP2 mutation type, location and X-inactivation in modulating Rett syndrome phenotype. Am J Med Genet (in press).
  • Willard HF, Hendrich BD. 1999. Breaking the silence in Rett syndrome. Nat Genet 23:127128.
  • Yntema HG, Oudakker AR, Kleefstra T, Hamel BCJ, Van Bokhoven H, Chelly J, Kalscheuer VM, Fryns JP, Raynaud M, Moizard MP, Moraine C. 2002. In-frame deletion in MECP2 causes mild nonspecific mental retardation. Am J Med Genet 107:8183.